Search Results - David Klements
- Showing 1 - 3 results of 3
-
1
The NeuroNEXT Gene Therapy Consortium: Designing and Advising on Quality Gene Therapy Trials in Rare and Ultra-rare Neurological Disorders by David Klements, MS, Marianne Chase, Hyun Joo (Sophie) Cho, Aleksander Videnovic, Christopher Coffey, Ph.D., Dixie Ecklund, R.N., M.S.N., M.B.A., Merit Cudkowicz, M.D., M.Sc.
Published in Neurotherapeutics (2025-07-01)Get full text
Article -
2
NeuroNEXT: A Summary of the First 12 Years & A Look Towards the Future by Christopher S. Coffey, Ph.D., Megan McCabe, M.S., Aleks Videnovic, M.D., Dixie Ecklund, Marianne Chase, Joan Ohayon, RN, MSN, CRNP, MSCN, Sophie Cho, M.D., Amy Tsou, M.D., M.Sc., Brenda Thornell, David Klements, Michele Costigan, RN, BSN, CCRC, Maria Houghton, J.D. M.S., Michael Moshinsky, B.S., Emily Roberts, Ph.D., Merit Cudkowicz, M.D., MSc.
Published in Neurotherapeutics (2024-07-01)Get full text
Article -
3
Effects of AFQ056 on language learning in fragile X syndrome by Elizabeth Berry-Kravis, Leonard Abbeduto, Randi Hagerman, Christopher S. Coffey, Merit Cudkowicz, Craig A. Erickson, Andrea McDuffie, David Hessl, Lauren Ethridge, Flora Tassone, Walter E. Kaufmann, Katherine Friedmann, Lauren Bullard, Anne Hoffmann, Jeremy Veenstra-VanderWeele, Kevin Staley, David Klements, Michael Moshinsky, Brittney Harkey, Jeff Long, Janel Fedler, Elizabeth Klingner, Dixie Ecklund, Michele Costigan, Trevis Huff, Brenda Pearson, NeuroNEXT FXLEARN Investigators
Published in The Journal of Clinical Investigation (2024-03-01)Get full text
Article
